- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Elixir Pharmaceuticals
Total 19566 results
-
Elixir PharmaceuticalsCompletedType 2 Diabetes Mellitus
-
Elixir PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
Elixir Medical CorporationRecruitingCoronary Artery DiseaseBelgium, Netherlands
-
Elixir Medical CorporationRecruiting
-
Elixir Medical CorporationCompletedCoronary Artery DiseaseNew Zealand, Belgium, Germany, Poland, Denmark, Brazil
-
Elixir Medical CorporationCompletedCoronary Artery DiseaseBelgium, Italy
-
Elixir Medical CorporationCompleted
-
Elixir Medical CorporationCompletedCoronary Artery DiseaseSwitzerland, New Zealand, Belgium, Poland, Australia, Brazil, Germany, Netherlands
-
Elixir Medical CorporationTerminated
-
Elixir Medical CorporationCompletedCoronary Artery DiseaseNew Zealand, Belgium
-
Elixir Medical CorporationActive, not recruitingCoronary Artery Disease | Coronary Disease | Coronary Stenosis | Coronary Artery StenosisNew Zealand, Belgium, Germany, Japan
-
Elixir Medical CorporationActive, not recruitingCoronary Artery DiseaseNew Zealand, Belgium, Netherlands, Czechia, Brazil
-
Elixir Medical CorporationCompleted
-
Elixir Medical CorporationCompletedCoronary Artery DiseaseBelgium, Brazil
-
Elixir Medical CorporationCompletedCoronary Artery DiseaseNew Zealand
-
Elixir Medical CorporationCompleted
-
University of ZurichLokman Hekim Üniversitesi; Elixir PharmaceuticalsCompletedCaffeine | Placebo | Sleep InertiaSwitzerland
-
Elixir Medical CorporationUppsala UniversityActive, not recruitingCoronary Artery Disease | Ischemic Heart DiseaseSweden
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Elicio TherapeuticsActive, not recruitingColorectal Cancer | Ovarian Cancer | Cholangiocarcinoma | Bile Duct Cancer | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma | Minimal Residual Disease | Gallbladder Carcinoma | KRAS G12D | KRAS G12R | NRAS G12D | NRAS G12RUnited States
-
Elixir Medical CorporationEuropean Cardiovascular Research CenterTerminated
-
Elixir Medical CorporationMassachusetts General Hospital; Syntactx; GenaeCompletedPeripheral Vascular DiseaseNew Zealand, Austria, Germany, Belgium
-
Elicio TherapeuticsRecruitingColorectal Cancer | Pancreatic Ductal Adenocarcinoma | KRAS G12D | KRAS G12R | NRAS G12D | NRAS G12R | KRAS G12V | KRAS G12C | KRAS G12A | KRAS G12S | KRAS G13D | NRAS G12V | NRAS G12C | NRAS G12SUnited States
-
Elixiron Immunotherapeutics Inc.Recruiting
-
Lihir Medical CentreCompletedTrauma | Lymphatic Filariasis | YawsPapua New Guinea
-
Lihir Medical CentreWithdrawnMalaria | Anaemia | Hyper-reactive Malarial SplenomegalyPapua New Guinea
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Elixiron Immunotherapeutics Inc.ParexelCompletedHealthy VolunteersUnited States
-
Elvir SASBioFortisCompletedCardiovascular Risk FactorsFrance
-
M.D. Anderson Cancer CenterEligixTerminatedCD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell TransplantationMultiple Myeloma | Chronic Lymphocytic Leukemia | Chronic Myelogenous Leukemia | Non Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Novartis PharmaceuticalsPharmaceutical Research AssociatesWithdrawn
-
Novartis PharmaceuticalsPharmaceutical Research AssociatesWithdrawn
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.CompletedOsteoarthritis, Knee | Osteoarthritis, HipUnited States
-
Enanta Pharmaceuticals, IncPharmaceutical Research AssociatesCompletedChronic HBV InfectionHong Kong, Taiwan
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.TerminatedOsteoarthritis | Chronic Low Back PainUnited States
-
Enanta Pharmaceuticals, IncPharmaceutical Research AssociatesCompletedRSV InfectionUnited States
-
Melior PharmaceuticalsBukwang Pharmaceutical, Co., Ltd.Completed
-
Tibotec Pharmaceuticals, IrelandTibotec Pharmaceutical LimitedCompletedHuman Immunodeficiency Virus 1South Africa, Argentina, Brazil, India, Kenya
-
Vertex Pharmaceuticals IncorporatedTibotec Pharmaceutical LimitedCompleted
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.TerminatedOsteoarthritis, Knee | Osteoarthritis, HipUnited States, Poland, United Kingdom
-
Enanta Pharmaceuticals, IncPharmaceutical Research AssociatesCompleted
-
Vertex Pharmaceuticals IncorporatedTibotec Pharmaceutical LimitedCompletedHepatitis CBelgium, United States, Puerto Rico, Netherlands
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.CompletedOsteoarthritis, Knee | Osteoarthritis, HipUnited States
-
Alexza Pharmaceuticals, Inc.Pharmaceutical Research AssociatesUnknownAgitation,PsychomotorUnited States
-
Enanta Pharmaceuticals, IncPharmaceutical Research AssociatesCompletedRSV InfectionUnited States
-
Vertex Pharmaceuticals IncorporatedTibotec Pharmaceutical LimitedCompletedHIV Infections | Hepatitis CFrance, Spain, United States, Germany
-
Tibotec Pharmaceuticals, IrelandTibotec Pharmaceutical LimitedCompletedHIV-1 InfectionFrance, United States, Spain, Ukraine, United Kingdom, Ireland
-
Ohio State UniversityVelimir MatkovicWithdrawnNeuromuscular Deficits | Musculoskeletal DeficitsUnited States